SecBot SecBot
SECBOTREPLAY Home › Report › CME

CME · Rothschild & Co double-upgraded CME Group from Neutral to Buy on June…

CME GROUP INC. · ANALYST-UPGRADE filed

At the news

BULLISHIMPACT 1/10

ANALYST-UPGRADE filed

Rothschild & Co double-upgraded CME Group from Neutral to Buy on June 11, 2026, raising its price target to $323 from $316, implying 22.4% upside from the current $263.80. Rothschild has a 57% accuracy rate on 40 calls and an average return of 3.1%, placing it below the top-tier firms covering CME. Consensus is split: 10 Buy (48%), 8 Hold (38%), 3 Sell (14%) across 21 analysts, with a mean price target of $305.47. Rothschild' s $323 target is above both the mean and median ($310). Over the past 30 days, only 1 upgrade has occurred, while EPS revisions have been net negative (11 downward revisions for the current quarter, 11 for this fiscal year). Insider activity is mixed: CEO Terry Duffy sold $7.75M in mid-May, while an insider bought $418K in March. Institutional moves show Bank of America and Capital Research adding, but Price T Rowe and Renaissance trimming. Short interest is elevated at 55.3%. The next earnings report is due July 21, 2026. The bullish call from a moderately accurate firm faces headwinds from insider selling and downward estimate revisions, but the double-upgrade signal is rare and merits attention.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access